Paper What Patients Should Know About Biologics

Event Report AfPA’s 2024 National Policy & Advocacy Summit Report

Paper Nurturing the Potential of the Biosimilar Market

One-Pager A Patient’s Guide to Self-Administered Biologics

Event Report National Policy & Advocacy Summit on Biologics – 2023

Survey Report Patient Choice: National Survey on Innovator Biologics and Biosimilars

Policy Brief Pharmacy Benefit Managers’ Impact on Patient Access

One-Pager Understanding Medicare Administrative Contractors

One-Pager Biosimilars vs. Generics

One-Pager Biologics, Biosimilars & Dermatology

One-Pager Biologics, Biosimilars & Cancer Care: Expert Perspectives

Event Report Report: 7th Annual National Policy & Advocacy Summit on Biologics

One-Pager Biologics, Biosimilars & Interchangeables

Fast Facts Policies to Support Older Americans

Video Innovator Biologics vs. Biosimilars vs. Interchangeables

One-Pager Biologics, Biosimilars & Neurological Disorders

Policy Brief Biologics & Biosimilars in Rheumatology

One-Pager Biologics & Asthma

Event Report National Policy & Advocacy Summit on Biologics

One-Pager Biologics, Biosimilars & Endocrinology

One-Pager Biologics, Biosimilars & Gastroenterology

One-Pager Biologics, Biosimilars & Oncology

Event Report & Social Images Prescriber Perspectives: Policies Impacting Biosimilar Access

One-Pager Biologics, Biosimilars & Rheumatic Disease

Video National Policy & Advocacy Summit on Biologics Recording

Event Report National Policy & Advocacy Summit on Biologics Report

Video Biologics and Biosimilars: Increasing Treatment Options

Survey Results Patients’ Understanding of Biological Medicines: Survey Findings

Meeting Report Making Biosimilars Work

Infographic Biologics & Biosimilars 101

One-Pager The Biosimilars Pathway 101

Infographic Is the Biosimilars Pathway Working for Patients?

Educational Video The Path to Approval

The Center for Biosimilars, Proposed CMS Changes Are the Wrong Way to Save Money and Will Harm Patients and Providers

Non-Medical Switching Principles and Guidelines

Updated Handbook The Biosimilar Promise: An Introduction for Prescribers

Biologics Prescribers Collaborative to Speak at FDA Hearing on Biosimilars

About the Biologics Prescribers Collaborative

The Biologics Prescribers Collaborative aims to ensure that sound policies are in place to promote the safest possible use of all biologics, including biosimilars, for all patients.

Learn More About Us

Co-conveners

Dennis R. Cryer, MD

Dennis R. Cryer, MD

Co-Convener | Biologics Prescribers Collaborative

Gregory Schimizzi, MD

Gregory Schimizzi, MD

Rheumatology

Wilmington, NC

David Charles, MD

David Charles, MD

Founder | Alliance for Patient Access

Arturo Loaiza-Bonilla, MD

Arturo Loaiza-Bonilla, MD

Oncology

Philadelphia, PA

Member Organizations